Dr. Rojas-Quintero is researching how Metformin, a long-used diabetes drug, may be able to slow fibrosis in the lungs.
An EHR-embedded inpatient care pathway for COPD was tied to improved adherence to evidence-based practices, shorter hospital ...
OSA and COPD present with symptoms that often go undetected for too long. How can clinicians recognize symptoms faster?
Saphnelo, which generated $304 million in sales in the first half of this year, is projected to achieve peak annual sales of ...
Achieve recently announced that the FDA accepted its cytisinicline New Drug Application for treatment of nicotine dependence for smoking cessation, with a PDUFA target action date of June 20, 2026.
TipRanks on MSN
GSK’s New COPD Study: A Potential Game-Changer?
GlaxoSmithKline (($GSK)) announced an update on their ongoing clinical study. GlaxoSmithKline (GSK) is launching a new clinical study titled A ...
Among patients with COPD, at least 50% reported that the disease impacts their daily life and emotional health, according to ...
Telemedicine-mediated follow-up for advanced chronic obstructive pulmonary disease potentially improves quality of life and ...
While COPD (chronic obstructive pulmonary disease) symptoms may start out as mild to moderate — with episodes of difficulty breathing that come and go — over time, COPD tends to get worse, and many ...
“Emphysema is usually a description of images — CT scan or X-ray — and is only one part of the disease of COPD,” says Uddalak Majumdar, MD, pulmonologist at the Cleveland Clinic in Ohio. COPD is ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results